Fecal transplants should be considered for patients with recurrent cases of Clostridium difficile whose symptoms cannot be addressed by antibiotics, the Infectious Diseases Society of America said in ...

Frozen fecal transplantation is effective at providing relief to Clostridium difficile (C. diff) patients, according to a new study co-authored by University of Guelph researchers. The study found ...

While hospitals are intended to be places of healing, people can acquire nasty infections with drug-resistant bacteria during a stay there. The bacterium Clostridioides difficile (C. diff) is ...

Fecal microbiota transplant might be considered for first-line treatment of Clostridioides difficile (C. diff), based on noninferiority findings from a randomized, open-label trial. A similar ...

Dear Dr. Roach: I had two previous episodes of C. diff and was treated with vancomycin. My stool tests the first time were negative. Recently, I got the same symptoms, and the doctor did a stool test ...

The intestinal infection, clostridium difficile — commonly known as C. difficile or C. diff — causes terrible diarrhea and abdominal cramping. In severe cases, C. diff also can cause bloody stools, a ...

WEBVTT ANTIBIOTICS CAN KNOCK OUT AN ILLNESS, BUT FOR SOME PEOPLE, THESE DRUGS CAN TRIGGER POTENTIALLY LIFE-THREATENING INFECTION, CAUSED BY A BACTERIA COMMONLY KNOWN AS C-DIFF. IT’S BASICALLY WHEN BAD ...

The Infectious Diseases Society of America and Society for Healthcare Epidemiology of America shared updated guidelines for diagnosing and treating Clostridium difficile infections Thursday. Here are ...

The Illinois Department of Public Health announced the publication of the first infection surveillance data on Clostridium difficile and methicillin-resistant Staphylococcus aureus rates from lab ...

What Is a Fecal Transplant? A fecal transplant is a procedure that places the stool of a healthy person into the colon of someone who’s ill. Your doctor may call it bacteriotherapy. A fecal transplant ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...